More Details Emerge on 340B Audit of Drug Manufacturer

by Admin | February 12, 2015 4:53 pm

February 12, 2015—More information about the first 340B program audit of a drug manufacturer emerged today during a drug industry government pricing conference in Washington. 

You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[1].    Already registered? Click here to login[2]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)
Endnotes:
  1. Click here to register: https://secure.340bhealth.org/340Binformed/Subscribe.aspx
  2. Click here to login: http://340binformed.org/reader-login/

Source URL: https://340binformed.org/2015/02/more-details-emerge-on-340b-audit-of-drug-manufacturer/

Copyright ©2024 340binformed.org unless otherwise noted.